Kineta to Present at the Oppenheimer 33rd Annual Healthcare

SEATTLE, March 08, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel......